Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 10Uterine Cervical Neoplasms 9Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Urinary Bladder Neoplasms 5Stomach Neoplasms 5Small Cell Lung Carcinoma 4Mesothelioma, Malignant 4Medulloblastoma 4Urethral Neoplasms 3Oropharyngeal Neoplasms 3Neuroblastoma 3Head and Neck Neoplasms 3Ganglioneuroblastoma 3Cholangiocarcinoma 3Vulvar Neoplasms 2Vaginal Neoplasms 2Ureteral Neoplasms 2Tongue Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Lymphoid Interstitial Pneumonia 2Gallbladder Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Brenner Tumor 2Brain Neoplasms 2Vomiting 1

Interventions

cediranib 3Pemetrexed 2pembrolizumab 1belinostat 1Watchful Waiting 1Platinum 1Pharmacogenomic Testing 1Dasatinib 1Cisplatin 1ARQ 197 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Solitary Fibrous Tumor, Pleural × Platinum × Clear all
NCT01064648 2026-05-29

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
117 enrolled 23 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡